Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben George

Showing results (51-60 of 124) with videos related to

Pageof 13
Sort By:
Physics in Medicine and Biology|January 15, 2021
IPEM topical report: guidance on the use of MRI for external beam radiotherapy treatment planning<sup></sup>Richard Speight, Michael Dubec, Cynthia L Eccles, et al.
BMC Cancer|June 20, 2006
The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancerAnirban P Mitra, Arpit A Almal, Ben George, et al.
BMJ Open|February 26, 2026
Protocol of the RADIO-STAR trial: a phase 1 safety and dose finding study of hypofractionated radiotherapy to the stellate ganglia for the treatment of ventricular arrhythmiaBenjamin Mothibe Bussmann, Ben George, Maxwell Robinson, et al.
American Journal of Surgery|December 14, 2020
Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoodsJavier Mora, Ashley N Krepline, Mohammed Aldakkak, et al.
Clinical and Translational Radiation Oncology|December 24, 2025
Daily adaptive MR-guided stereotactic ablative re-irradiation (re-SABR) in oligometastatic liver disease: A single-institution retrospective analysisElena Moreno-Olmedo, Dan Murray, Ben George, et al.
Frontiers in Oncology|December 19, 2019
Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With <i>nab</i>-Paclitaxel and Carboplatin in Advanced Non-small Cell Lung CancerJonathan W Goldman, David M Waterhouse, Ben George, et al.
The Oncologist|February 27, 2014
Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm?Kathleen K Christians, Susan Tsai, Anna Mahmoud, et al.
Plos One|October 9, 2015
Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Colorectal Liver Metastases: A Meta-AnalysisAnthony J Zacharias, Thejus T Jayakrishnan, Rahul Rajeev, et al.
The Oncologist|February 17, 2026
MEK inhibitor-based genomically matched combinatorial targeted therapies in metastatic pancreatic adenocarcinoma with KRAS alterationsElizabeth D Auckley, Stephanie Yohay, Grace Ying, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2007
p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancerBen George, Ram H Datar, Lin Wu, et al.
Pageof 13

Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
Physics in Medicine and Biology|January 15, 2021
IPEM topical report: guidance on the use of MRI for external beam radiotherapy treatment planning<sup></sup>Richard Speight, Michael Dubec, Cynthia L Eccles, et al.
BMC Cancer|June 20, 2006
The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancerAnirban P Mitra, Arpit A Almal, Ben George, et al.
BMJ Open|February 26, 2026
Protocol of the RADIO-STAR trial: a phase 1 safety and dose finding study of hypofractionated radiotherapy to the stellate ganglia for the treatment of ventricular arrhythmiaBenjamin Mothibe Bussmann, Ben George, Maxwell Robinson, et al.
American Journal of Surgery|December 14, 2020
Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoodsJavier Mora, Ashley N Krepline, Mohammed Aldakkak, et al.
Clinical and Translational Radiation Oncology|December 24, 2025
Daily adaptive MR-guided stereotactic ablative re-irradiation (re-SABR) in oligometastatic liver disease: A single-institution retrospective analysisElena Moreno-Olmedo, Dan Murray, Ben George, et al.
Frontiers in Oncology|December 19, 2019
Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With <i>nab</i>-Paclitaxel and Carboplatin in Advanced Non-small Cell Lung CancerJonathan W Goldman, David M Waterhouse, Ben George, et al.
The Oncologist|February 27, 2014
Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm?Kathleen K Christians, Susan Tsai, Anna Mahmoud, et al.
Plos One|October 9, 2015
Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Colorectal Liver Metastases: A Meta-AnalysisAnthony J Zacharias, Thejus T Jayakrishnan, Rahul Rajeev, et al.
The Oncologist|February 17, 2026
MEK inhibitor-based genomically matched combinatorial targeted therapies in metastatic pancreatic adenocarcinoma with KRAS alterationsElizabeth D Auckley, Stephanie Yohay, Grace Ying, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2007
p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancerBen George, Ram H Datar, Lin Wu, et al.
Pageof 13